Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: OBC patients treated at TMH ER +/Her2 neg or TNBC We will include2780 women wherein events / 5-year follow up is available. We propose to have a blinded member of the DMG identify such cases and provide to the study team.
Exclusion criteria
Exclusion criteria: Missing variables egpT size, chemotherapy details Lost to follow up Her2 overexpression positive or Equivocal on IHC. (This is being excluded to avoid the bias of incomplete treatment as a large number of patients treated in 2010-2013may not have received Her2 targeted treatment in our setting)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the observed 5 year overall survival of operable breast cancer patients with the one predicted by PREDICT V2.0.Timepoint: from diagnosis to 5 years survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Subgroup analysis ( age, grade , molecular classification ) wherein the observed 5 year overall survival will be compared with the one predicted by PREDICT V2. in the specified subgroups.Timepoint: from diagnosis to 5 years survival | — |
Countries
India
Contacts
Tata Memorial Central